The Team

is based in Berlin

We look for investors!

Chemistry & Drug Synthesis:

Thomas Rupp, Scientist

Over 30 years of technical experience in oligonucleotide manufacturing and analytics, Thomas Rupp is a very well-recognized expert and go-to-person in the oligonucleotide field; since mid-2013 Thomas Rupp works as an independent technical and regulatory CMC consultant in the field of therapeutic oligonucleotides.

Scientific Expert

Prof. Georg Sczakiel, PhD

One of major players in the field of academic research and pre-commercial R&D of nucleic acid-based drugs for nearly 30 years; Co-founder of the oligonucleotide therapeutics society (OTS), well established and trustful relationships within academia & industry; Director of the Institute of Molecular Medicine (IMM) of the University of Lübeck, Germany. Transferpreisträger (Preis für beispielgebende Projektaktivitäten im Technologietransfer der Universität zu Lübeck.

Finance & Communication

Alex Zeh, Financial Engineer

With 20 years of working with multinationals as well as technology startup companies in the field of financial, reporting, controlling, management and consulting Alex cares for finance and investor relations. Experienced with a biotech prime standard stock listed R&D company; he cares for strategy, partnering, business orientation and financial affairs.